Patient Characteristics (n = 242)
| Characteristic | Data |
|---|---|
| Age at PET (y) | 72 (44–86) |
| ISUP grade group | |
| I | 14 (5.7%) |
| II | 69 (28.5%) |
| III | 52 (21.5%) |
| IV | 27 (11.2%) |
| V | 38 (15.7%) |
| Unknown | 42 (17.4%) |
| Pathologic primary tumor staging (pT) | |
| pT2 | 95 (39.3%) |
| pT3 | 111 (45.9%) |
| pT4 | 3 (1.2%) |
| Unknown | 33 (13.6%) |
| Pathologic regional lymph node staging (pN) | |
| pN0 | 151 (62.4%) |
| pN1 | 36 (14.9%) |
| pNx | 55 (22.7%) |
| Positive margin | |
| R0 | 136 (56.2%) |
| R1 | 44 (18.2%) |
| Unknown | 62 (25.6%) |
| Initial PSA value (ng/mL) | 10.5 (3–177) |
| Time between surgery and PET (mo) | 50 (3–1437) |
| Last PSA value before PET (ng/mL) | 0.60 (0.2–60.8) |
| Injected activity (MBq) | 332 (206–454) |
| Uptake time (min) | 73 (58–117) |
*PSA value obtained within 4 wk preceding 18F‐rhPSMA‐7 PET examination.
ISUP = International Society of Urologic Pathologists.
Qualitative data are number and percentage; continuous data are median and range.